
Photo courtesy of Joanne DeCaro
As millions of opioid settlement dollars flow into states, substance use disorder experts at AHCJ’s Rural Health Workshop 2022 said reporters should “follow the money” and hold officials and programs accountable for using that money to fund evidence-based programs.
“That’s what we didn’t see implemented and really borne out within the tobacco settlement,” said Sonia Canzater, J.D., M.P.H., associate director of the Hepatitis Policy Project at the O’Neill Institute for National and Global Health Law at Georgetown University, referring to the $246 billion major U.S. tobacco companies agreed to pay states in 1998 over 25 years as part of the Master Settlement Agreement.
Similar to that pact, pharmaceutical companies have agreed to pay roughly $26 billion to settle a barrage of lawsuits from states that allege those companies are partly to blame for the nation’s deadly opioid epidemic.
Brian Winbigler, Pharm.D., M.B.A., an assistant professor in the Department of Clinical Pharmacy and Translational Science at the University of Tennessee College of Pharmacy, said opioid settlement funds should go to evidence-based programs, such as those that facilitate medication-assisted treatment and harm-reduction programs.